BURACCHI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 1.087
EU - Europa 575
AS - Asia 278
SA - Sud America 9
OC - Oceania 3
AF - Africa 2
Totale 1.954
Nazione #
US - Stati Uniti d'America 1.073
IT - Italia 162
SG - Singapore 129
IE - Irlanda 114
SE - Svezia 79
RU - Federazione Russa 78
DE - Germania 67
HK - Hong Kong 53
CN - Cina 48
GB - Regno Unito 24
IN - India 18
FI - Finlandia 17
CA - Canada 14
ID - Indonesia 13
VN - Vietnam 9
UA - Ucraina 7
CZ - Repubblica Ceca 5
AR - Argentina 4
BE - Belgio 4
BR - Brasile 4
AL - Albania 3
FR - Francia 3
NL - Olanda 3
PK - Pakistan 3
AU - Australia 2
CH - Svizzera 2
IL - Israele 2
LT - Lituania 2
RS - Serbia 2
AZ - Azerbaigian 1
CO - Colombia 1
ES - Italia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RO - Romania 1
SC - Seychelles 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 1.954
Città #
Ann Arbor 397
Singapore 115
Dublin 111
Chandler 75
Fairfield 59
New York 58
Hong Kong 53
Frankfurt am Main 43
Ashburn 41
Wilmington 35
Milan 32
Woodbridge 31
Santa Clara 29
Seattle 25
Shanghai 21
Houston 20
Princeton 20
Lissone 19
Cambridge 16
Helsinki 16
Pune 15
Jakarta 13
Fremont 10
Lawrence 10
Altamura 8
Dong Ket 8
Rome 8
London 7
Toronto 6
Dearborn 5
Garbagnate Milanese 5
Munich 5
Beauharnois 4
Brno 4
Brussels 4
Chicago 4
Contursi 4
Nanjing 4
Turin 4
West Jordan 4
Acquafredda 3
Andover 3
Boardman 3
Bologna 3
Cerreto Guidi 3
Dallas 3
Faisalabad 3
Guangzhou 3
Hangzhou 3
Muggiò 3
Norwalk 3
San Diego 3
Somma Lombardo 3
Bahía Blanca 2
Bath 2
Berlin 2
Bonndorf 2
Brescia 2
Carate 2
Genova 2
Grafing 2
Gunzenhausen 2
Jacksonville 2
Jinan 2
Kilburn 2
Lugano 2
Ottawa 2
Redmond 2
Rho 2
Shenyang 2
Stockholm 2
Sydney 2
Torino 2
Vila Velha 2
Wuhan 2
Amsterdam 1
Arezzo 1
Auckland 1
Baku 1
Bari 1
Barnet 1
Baschi 1
Bogotá 1
Boston 1
Brugherio 1
Böblingen 1
Carate Brianza 1
Castelleone 1
Centurion 1
Changsha 1
Chengdu 1
Clearwater 1
Como 1
Cordovado 1
Coventry 1
Curitiba 1
Desio 1
Edmonton 1
Falls Church 1
Florence 1
Totale 1.456
Nome #
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System 244
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 240
Flow cytometry for minimal residual disease testing in acute leukemia: opportunities and challenges 165
Single-cell profiling of pediatric T-cell acute lymphoblastic leukemia: Impact of PTEN exon 7 mutation on PI3K/Akt and JAK–STAT signaling pathways 154
SRC/ABL inhibition disrupts CRLF2-driven signaling to induce cell death in B-cell acute lymphoblastic leukemia 146
Differential expression of CD73, CD86 and CD304 in normal vs. leukemic B-cell precursors and their utility as stable minimal residual disease markers in childhood B-cell precursor acute lymphoblastic leukemia 142
Monocyte–macrophage polarization and recruitment pathways in the tumour microenvironment of B-cell acute lymphoblastic leukaemia 127
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 108
Flow cytometric minimal residual disease assessment in B-cell precursor acute lymphoblastic leukaemia patients treated with CD19-targeted therapies — a EuroFlow study 58
Phenotypic profiling of CD34+ cells by advanced flow cytometry improves diagnosis of Juvenile Myelomonocytic Leukemia 55
Impact of Pre-Analytical and Analytical Variables Associated with Sample Preparation on Flow Cytometric Stainings Obtained with EuroFlow Panels 53
Targeted gene correction in osteopetrotic-induced pluripotent stem cells for the generation of functional osteoclasts 50
Deep immunophenotypic characterization of CARCIK-CD19 pre-infusion cellular product by advanced multiparametric flow cytometry 47
The atypical chemokine receptor ACKR2 drives pulmonary fibrosis by tuning influx of CCR2+ and CCR5+ IFNγ-producing γδT cells in mice 46
Megakaryocytes contribute to the bone marrow-matrix environment by expressing fibronectin, type IV collagen, and laminin 41
Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia 40
Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family 36
Bone Marrow Stromal Cell Regeneration Profile in Treated B-Cell Precursor Acute Lymphoblastic Leukemia Patients: Association with MRD Status and Patient Outcome 35
Automated database-guided expert-supervised orientation for immunophenotypic diagnosis and classification of acute leukemia 35
Functional TRAIL receptors in monocytes and tumor-associated macrophages: A possible targeting pathway in the tumor microenvironment 35
Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia 34
Automated identification of leukocyte subsets improves standardization of database-guided expert-supervised diagnostic orientation in acute leukemia: a EuroFlow study 27
Control of murine Ly6Chigh monocyte traffic and immunosuppressive activities by atypical chemokine receptor D6 27
Minimal residual disease assessment in B-cell precursor acute lymphoblastic leukemia by semi-automated identification of normal hematopoietic cells: A EuroFlow study 27
Differential effects of immunosuppressive drugs on chemokine receptor CCR7 in human monocyte-derived dendritic cells: Selective upregulation by rapamycin 26
Increased inflammation in mice deficient for the chemokine decoy receptor D6 21
TNF-α and the IFN-γ-inducible protein 10 (IP-10/CXCL-10) delivered by parvoviral vectors act in synergy to induce antitumor effects in mouse glioblastoma 17
Diverse mechanisms of leukemogenesis associated with PAX5 germline mutation 15
Totale 2.051
Categoria #
all - tutte 10.777
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.777


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202044 0 0 0 0 0 9 7 4 6 2 4 12
2020/2021466 10 40 71 39 46 44 34 36 31 39 38 38
2021/2022257 31 39 31 19 17 23 5 10 24 19 17 22
2022/2023373 31 82 34 22 4 36 14 79 37 2 21 11
2023/2024438 13 8 17 45 55 109 91 10 25 14 4 47
2024/2025393 45 122 44 55 101 26 0 0 0 0 0 0
Totale 2.051